advertisement
Classification List
- 1 General aspects0
- 1.1 Epidemiology20
- 1.2 Population genetics3
- 1.3 Pathogenesis0
- 1.4 Quality of life7
- 1.5 Glaucomas as cause of blindness8
- 1.6 Prevention and screening8
- 2 Anatomical structures in glaucoma0
- 2.1 Conjunctiva8
- 2.2 Cornea27
- 2.3 Sclera2
- 2.4 Anterior chamber angle2
- 2.5 Meshwork0
- 2.5.1 Trabecular meshwork8
- 2.5.2 Schlemms canal3
- 2.5.3 Scleral outlet channels0
- 2.6 Aqueous humor dynamics0
- 2.6.1 Production2
- 2.6.2 Outflow1
- 2.6.2.1 Trabecular meshwork5
- 2.6.2.2 Uveoscleral0
- 2.6.3 Compostion8
- 2.7 Episcleral veins and venous pressure0
- 2.8 Iris4
- 2.9 Ciliary body1
- 2.10 Lens1
- 2.11 Vitreous body1
- 2.12 Choroid, peripapillary choroid, peripapillary atrophy3
- 2.13 Retina and retinal nerve fibre layer22
- 2.14 Optic disc22
- 2.15 Optic nerve1
- 2.16 Chiasma and retrochiasmal central nervous system4
- 2.17 Stem cells2
- 2.20 Other0
- 3 Laboratory methods0
- 3.1 Microscopy2
- 3.2 Electron microscopy2
- 3.3 Immunohistochemistry5
- 3.4 Molecular genetics0
- 3.4.1 Linkage studies1
- 3.4.2 Gene studies36
- 3.5 Molecular biology incl. SiRNA11
- 3.6 Cellular biology34
- 3.7 Biochemistry10
- 3.8 Pharmacology19
- 3.9 Pathophysiology7
- 3.10 Immunobiology11
- 3.11 Pharmacogenetics0
- 3.12 Proteomics2
- 3.13 In vivo imaging0
- 3.13.1 Laser Scanning0
- 3.13.1.1 Confocal Scanning Laser Ophthalmoscopy0
- 3.13.1.2 Confocal Scanning Laser Polarimetry0
- 3.13.2 Optical Coherence Tomography0
- 3.13.2.1 Anterior Segment0
- 3.13.2.2 Posterior Segment0
- 3.13.3 RGC Imaging3
- 3.13.4 Other0
- 3.20 Other0
- 4 Tissue culture of ocular cells0
- 5 Experimental glaucoma; animal models0
- 5.1 Rodent46
- 5.2 Primates3
- 5.3 Other22
- 6 Clinical examination methods0
- 6.1 Intraocular pressure measurement; factors affecting IOP0
- 6.1.1 Devices, techniques15
- 6.1.2 Fluctuation, circadian rhythms7
- 6.1.3 Factors affecting IOP26
- 6.2 Tonography, aqueous flow measurement (see also 2.6)3
- 6.3 Biomicroscopy (slitlamp)0
- 6.3.1 Anterior segment1
- 6.3.2 Posterior segment1
- 6.4 Gonioscopy0
- 6.5 Ophthalmoscopy2
- 6.6 Visual field examination and other visual function tests0
- 6.6.1 Conventional manual0
- 6.6.2 Automated21
- 6.6.3 Special methods (e.g. color, contrast, SWAP etc.)14
- 6.7 Electro-ophthalmodiagnosis8
- 6.8 Photography0
- 6.8.1 Anterior segment3
- 6.8.2 Posterior segment11
- 6.9 Computerized image analysis0
- 6.9.1 Laser scanning0
- 6.9.1.1 Confocal Scanning Laser Ophthalmoscopy16
- 6.9.1.2 Confocal Scanning Laser Polarimetry8
- 6.9.2 Optical coherence tomography0
- 6.9.2.1 Anterior10
- 6.9.2.2 Posterior46
- 6.9.5 Other0
- 6.10 Fluorescein (ICG) angiography0
- 6.10.1 Anterior segment0
- 6.10.2 Posterior segment3
- 6.11 Bloodflow measurements 26
- 6.12 Ultrasonography and ultrasound biomicroscopy6
- 6.13 Provocative tests1
- 6.19 Telemedicine1
- 6.20 Progression7
- 6.30 Other0
- 8 Refractive errors in relation to glaucoma0
- 8.1 Myopia4
- 8.2 Hypermetropia0
- 8.3 Contact lenses0
- 8.4 Refractive surgical procedures0
- 8.5 Other0
- 9 Clinical forms of glaucomas0
- 9.1 Developmental glaucomas0
- 9.1.1 Congenital glaucoma, Buphthalmos7
- 9.1.2 Juvenile glaucoma13
- 9.1.3 Syndromes of Axenfeld, Rieger, Peters, aniridia4
- 9.1.4 Other0
- 9.2 Primary open angle glaucomas0
- 9.2.1 Ocular hypertension3
- 9.2.2 Other risk factors for glaucoma4
- 9.2.3 Open angle glaucoma with elevated IOP4
- 9.2.4 Normal pressure glaucoma15
- 9.3 Primary angle closure glaucomas0
- 9.3.1 Acute primary angle closure glaucoma (pupillary block)13
- 9.3.2 Chronic primary angle closure glaucoma (pupillary block)5
- 9.3.3 Plateau iris syndrome0
- 9.3.4 Primary angle closure suspect2
- 9.3.5 Primary angle closure6
- 9.3.10 Other0
- 9.4 Glaucomas associated with other ocular and systemic disorders0
- 9.4.1 Steroid-induced glaucoma5
- 9.4.2 Glaucomas associated with disorders of the cornea, conjunctiva, sclera0
- 9.4.2.1 Iridocorneal endothelial syndrome (ICE, incl. irisatrophy)0
- 9.4.2.2 Posterior polymorphous dystrophy0
- 9.4.2.3 Fuchs' endothelial dystrophy0
- 9.4.2.5 Other0
- 9.4.3 Glaucomas associated with disorders of the iris and ciliary body0
- 9.4.3.1 Pigmentary glaucoma2
- 9.4.3.5 Other0
- 9.4.4 Glaucomas associated with disorders of the lens0
- 9.4.4.1 Exfoliation syndrome14
- 9.4.4.2 Glaucomas associated with cataracts4
- 9.4.4.3 Glaucomas associated with lens dislocation0
- 9.4.4.5 Other4
- 9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous0
- 9.4.5.1 Neovascular glaucoma7
- 9.4.5.5 Other1
- 9.4.6 Glaucomas associated with inflammation, uveitis 6
- 9.4.7 Glaucomas associated with ocular trauma0
- 9.4.8 Glaucomas associated with intraocular tumors1
- 9.4.9 Glaucomas associated with elevated episcleral venous pressure1
- 9.4.10 Glaucomas associated with hemorrhage2
- 9.4.11 Glaucomas following intraocular surgery0
- 9.4.11.1 Ciliary block (malignant) glaucoma4
- 9.4.11.2 Glaucomas in aphakia and pseudophakia6
- 9.4.11.3 Epithelial, fibrous, and endothelial proliferation0
- 9.4.11.4 Glaucomas associated with corneal surgery6
- 9.4.11.5 Glaucomas associated with vitreoretinal surgery4
- 9.4.15 Glaucoma in relation to systemic disease24
- 9.4.20 Other1
- 10 Differential diagnosis e.g. anterior and posterior ischemic optic neuropathy6
- 11 Medical treatment0
- 11.1 General management, indication2
- 11.2 Cholinergic drugs0
- 11.3 Adrenergic drugs0
- 11.3.1 Epinephrine0
- 11.3.2 Thymoxamine, dapiprazole0
- 11.3.3 Apraclonidine, brimonidine4
- 11.3.4 Betablocker7
- 11.3.5 Other0
- 11.4 Prostaglandins19
- 11.5 Carbonic anhydrase inhibitors0
- 11.5.1 Systemic1
- 11.5.2 Topical7
- 11.6 Osmotic treatment0
- 11.7 Treatment of bloodflow1
- 11.8 Neuroprotection43
- 11.9 Gene therapy1
- 11.13 Combination therapy0
- 11.13.1 Betablocker and pilocarpine0
- 11.13.2 Betablocker and carbon anhydrase inhibitor6
- 11.13.3 Betablocker and brimonidine1
- 11.13.4 Betablocker and prostaglandin6
- 11.13.5 Other0
- 11.14 Investigational drugs; pharmacological experiments20
- 11.15 Other drugs in relation to glaucoma13
- 11.16 Vehicles, delivery systems, pharmacokinetics, formulation23
- 11.17 Cooperation with medical therapy e.g. persistency, compliance, adherence8
- 11.20 Other3
- 12 Surgical treatment0
- 12.1 General management, indication2
- 12.2 Laser iridotomy3
- 12.3 Laser iridoplasty0
- 12.4 Laser trabeculoplasty and other laser treatment of the angle8
- 12.7 Surgical iridectomy1
- 12.8 Filtering surgery0
- 12.8.1 Without tube implant20
- 12.8.2 With tube implant or other drainage devices26
- 12.8.3 Non-perforating10
- 12.8.4 Using laser0
- 12.8.5 Other0
- 12.8.10 Woundhealing antifibrosis26
- 12.8.11 Complications, endophthalmitis5
- 12.9 Trabeculotomy, goniotomy0
- 12.10 Cyclodestruction7
- 12.11 Cyclodialysis0
- 12.12 Cataract extraction0
- 12.12.1 Intracapsular0
- 12.12.2 Extracapsular1
- 12.12.3 Phacoemulsification7
- 12.14 Combined cataract extraction and glaucoma surgery0
- 12.14.1 Intracapsular0
- 12.14.2 Extracapsular1
- 12.14.3 Phacoemulsification5
- 12.15 Capsulotomy0
- 12.16 Vitrectomy1
- 12.17 Anesthesia4
- 12.20 Other 3
- 13 Therapeutic prognosis and outcome0
- 13.1 Prognostic factors0
- 13.2 Outcome0
- 13.2.1 IOP0
- 13.2.2 Visual field0
- 13.2.2.1 Progression2
- 13.2.2.2 Improvement1
- 13.2.3 Other0
- 14 Costing studies; pharmacoeconomics6
- 15 Miscellaneous25